![Cover Image for SBIR/STTR Application to NIH - How to succeed! w/ PASCALL [online]](https://images.lumacdn.com/cdn-cgi/image/format=auto,fit=cover,dpr=2,background=white,quality=75,width=400,height=400/gallery-images/4p/23e6b8bd-968e-40be-8ba4-7b723aee77b9)
SBIR/STTR Application to NIH - How to succeed! w/ PASCALL [online]
Objective: How we never failed an STTR/SBIR grant application to NIH: pitfalls and best practices
Who Should Attend:
StartX founders interested in utilizing NIH as a key funding mechanism for your startups
Two of PASCALL founders will be leading this roundtable
Tuan Le Mau, Ph.D (MIT), PASCALL's co-founder and CEO
Patrick Purdon, Ph.D., co-founder, and currently professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University.
About PASCALL Systems:
Our vision is to bring personalized, innovative, and strong science-based anesthesia care to all hospitals in the world to improve postoperative outcomes starting with prevention of post-operative delirium and opioid use and dependence. We achieved ISO13485:2016 certification for the design and development of medical devices. Our first EEG monitor platform was FDA-510(k) cleared in 2022. Our activities are funded privately and by 6 NIH fast-tracked (Phase I + II) STTR/SBIR grants from NIH National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA) and National Institute of Neurological Disorders and Stroke (NINDS).